Acute toxicity in patients with oligometastatic cancer following metastasis-directed stereotactic body radiotherapy: An interim analysis of the E2-RADIatE OligoCare cohort-Reference-Cited by-同舟云学术

Acute toxicity in patients with oligometastatic cancer following metastasis-directed stereotactic body radiotherapy: An interim analysis of the E2-RADIatE OligoCare cohort

Published:2024-10 Issue: Volume:199 Page:110466
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Alongi Filippo,Nicosia Luca,Ricardi Umberto,Scorsetti Marta,Greto Daniela,Balermpas Panagiotis,Lievens Yolande,Braam Pètra,Jereczek-Fossa Barbara Alicja,Stellamans Karin,Ratosa Ivica,Simek Inga-Malin,Peulen Heike,Dirix Piet,Verbeke Luc,Ramella Sara,Hemmatazad Hossein,Khanfir Kaouthar,Geets Xavier,Jeene Paul,Zilli Thomas,Fournier Beatrice,Fortpied Catherine,Boakye Oppong Felix,Ost Piet,Guckenberger Matthias

Publisher

Elsevier BV

Reference24 articles.

1. Local consolidative therapy versus maintenance therapy or observation for patients with oligometastatic non-small-cell lung cancer without progression after first-line systemic therapy: a multicentre, randomised, controlled, phase 2 study;Gomez;Lancet Oncol,2016

2. Surveillance or Metastasis-Directed Therapy for Oligometastatic Prostate Cancer Recurrence: A Prospective, Randomized, Multicenter Phase II Trial;Ost;J Clin Oncol,2018

3. Consolidative Radiotherapy for Limited Metastatic Non-Small-Cell Lung Cancer: A Phase 2 Randomized Clinical Trial;Iyengar;JAMA Oncol,2018

4. Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial;Palma;Lancet,2019

5. Outcomes of Observation vs Stereotactic Ablative Radiation for Oligometastatic Prostate Cancer: The ORIOLE Phase 2 Randomized Clinical Trial;Phillips;JAMA Oncol,2020